Cure Alzheimer's Fund Cure Alzheimer's Fund

Evaluating TMEM106B Accumulation in Alzheimer’s Disease

2022, 2023

Recent studies investigating a new type of filament found in patients with Alzheimer’s disease and related disorders identified TMEM106B, a protein normally localized to the lysosome, as the protein constituent. The current project is focused on developing new tools to label TMEM106B, and to understand the significance of TMEM106B filament accumulation and its relationship to the disease course.

Casey Cook Leonard Petrucelli Studies of Alternative Neurodegenerative Pathways Translational

Funding to Date

$402,500

Focus

Studies of Alternative Neurodegenerative Pathways, Translational

Researchers

Leonard Petrucelli, Ph.D.

Casey Cook, Ph.D.

Related Content:


Dysregulation of Signaling on Post Synaptic Density Scaffolds in Alzheimer’s Disease Alexandra C. Newton 2024-07-29 Novel Artificial Intelligence (AI) Decodes Aging Neurons Andrew J. Holbrook Theodore Zwang 2024-07-23 2-Deoxyglucose and Its Analogs as Novel Therapeutics to Build Resilience to Alzheimer’s Disease Rajiv R. Ratan Theodore J. Lampidis 2024-07-23 The Role of Calcium Homeostasis in Axonal Spheroid Formation in Alzheimer’s Disease Jaime Grutzendler 2024-06-13 Brain Entry and Exit Consortium: Neuroinflammation at the Choroid Plexus in Alzheimer’s Disease Maria Lehtinen 2024-05-02 Brain Entry and Exit Consortium: Does Subarachnoid Lymphatic-Like Membrane Failure Compromise Glymphatic Clearance in Alzheimer’s Disease? Maiken Nedergaard 2024-05-02 Brain Entry and Exit Consortium: High-Resolution Magnetic Resonance Imaging of the Brain Borders Daniel S. Reich 2024-05-02 Brain Exit and Entry Consortium: Human Three-Dimensional Neurovascular Interaction and Meningeal Lymphatics Models with Application to Alzheimer’s Disease Se Hoon Choi 2024-05-02